Cambridge Healthtech Institute’s Inaugural

Digital Therapeutics

Integrating Evidence-Based and Clinically-Validated DTx into Medicine

June 2-4, 2020


TUESDAY, JUNE 2

7:30 am Registration and Morning Coffee

PLENARY SESSION: DIGITAL TRANSFORMATION IN HEALTHCARE

8:30 Chairperson’s Opening Remarks

8:35 Bringing Digital to Life: Transforming Healthcare and Patient Experience Using Human-Centered Design and Digital Solutions
Neil Gomes, MBA, Med, CSM, CSPO, Executive Vice President for Tech, Innovation & Consumer Experience, Enterprise Chief Digital Officer, Thomas Jefferson University & Jefferson Health
In this keynote presentation, Neil Gomes, Chief Digital Officer and Executive Vice President for Technology Innovation and Consumer Experience at Thomas Jefferson University and Jefferson Health, provides insights into how healthcare organizations can start to disrupt themselves by leveraging their experience in the industry to develop a better experience for their patients. This translates into developing not just digital health solutions, but creating new business models for healthcare that are focused on access, convenience, and experience; developing clinical process that embrace the principles of human-centered design; and making strategic investments in developing a culture of continuous transformative innovation at healthcare organizations. With the insights and real-world examples that utilize modern technologies such as artificial intelligence and machine learning, augmented and virtual reality, robotic process automation, dynamic decision systems, etc. that are part of this presentation, you will be able to embrace, define, and lead the consumer-focused, design-driven, and technology-enabled future of healthcare.

9:00 Driving Digital Transformation Success
Claus Jensen, PhD, Chief Digital Officer & Head of Technology, Memorial Sloan Kettering Cancer Center
While digital transformation is a hot topic in most organizations, statistics show that 9 out of 10 digital transformation initiatives actually fail to meet expectations – and the numbers having improved much since the emergence of Digital 2.0 imperatives. Join this session to discuss why digital transformation is so difficult, and what to do about it in order to improve your odds of success.

9:25 Delivering Digital Health in a Consumer Health World
Chet Robson, DO, MHCDS, FAAFP, Chief Clinical Officer, Walgreens
As patients take on more of the role of consumer it is valuable to understand how consumers discover, navigate, choose and utilize digital resources. This session explores how one retail healthcare company delivers digital assets for personal health, patient engagement, clinical research, and digital therapeutics.

9:50 Sponsored Presentation (Opportunity Available)

10:15 Coffee Break with Exhibit and Poster Viewing

11:00 The Future of Health Has Arrived: The Rise of Smart Health Communities
Asif Dhar, MD, MBA, Chief Health Informatics Officer, Principal, Deloitte Consulting LLP

11:25 Digital Health Is Here: How Will It Affect Your Health and the Health of Your Business?
Joseph C. Kvedar, MD, Professor, Dermatology, Harvard Medical School; Senior Advisor, Virtual Care, Partners HealthCare
The stark reality is that soon there will not be enough clinicians to care for our citizens sufficiently. Instead of relying on the more traditional and already overburdened one-to-one model, we must adopt technology that enables one-to-many care delivery models. In particular, artificial intelligence (AI) and other emerging technologies allow for outsourcing of routine tasks to machines, creating space in the schedule for human interaction between clinician and patient. How can we apply digital and telehealth to improve care delivery, patient and clinician satisfaction, and clinical outcomes?

11:50 PANEL DISCUSSION: Drivers in Digital Transformation
Moderator: Neil Gomes, MBA, Med, CSM, CSPO, Executive Vice President, Tech, Innovation & Consumer Experience, Enterprise Chief Digital Officer, Thomas Jefferson University & Jefferson Health
Panelists to be Announced

12:30 pm Luncheon Presentation (Sponsorship Opportunity Available) or Enjoy Lunch on Your Own

1:00 Session Break

PARTNERING STRATEGIES FOR PRESCRIPTION DIGITAL THERAPEUTICS

2:00 Chairperson’s Remarks

2:05 Prescription DTx
Alex Waldron, Chief Strategy Officer, Pear Therapeutics

2:30 Presentation to be Announced

2:55 Sponsored Presentation (Opportunity Available)

3:10 PANEL DISCUSSION: Partnering Strategies for Digital Therapeutics
Moderator: Alex Waldron, Chief Strategy Officer, Pear Therapeutics

4:00 Refreshment Break with Exhibit and Poster Viewing

PLENARY SESSION: BRIDGING SILOS: AN INTEGRATED APPROACH TO DIGITAL HEALTH

4:45 Chairperson’s Remarks

4:50 Commercialization, Regulatory and Partnering Strategies with Provider, Payers, Hub, Industry for Digital
Karan Arora, MBA, Chief Commercial Digital Officer, Global Vice President, AstraZeneca

5:15 Sponsored Presentation (Opportunity Available)

5:30 PANEL DISCUSSION: An Integrated Approach to Data Silos, Collaboration and Patient-Centricity

6:00 Welcome Networking Reception with Exhibit and Poster Viewing

7:00 Close of Day

7:00-9:30 Dinner Short Course (separate registration required)


WEDNESDAY, JUNE 3

8:00 am Morning Coffee

PLENARY SESSION: DIGITAL HEALTH INNOVATION

8:30 PANEL DISCUSSION: Investing in Digital Health Innovation
Moderator: Lisa Suennen, Lead, Digital & Technology Group, Manatt Ventures; Managing Director, Manatt Health
Panelists: David Kim, Managing Director, DigiTx
Additional Panelists to be Announced

9:30 Coffee Break with Exhibit and Poster Viewing

10:15 Chairperson’s Remarks
Lisa Suennen, Lead, Digital & Technology Group, Manatt Ventures; Managing Director, Manatt Health

10:20 Delivering Global Comprehensive Virtual Care at Scale
Lewis Levy, MD, FACP, CMO, Teladoc

10:45 Presentation to be Announced

11:10 Presentation to be Announced

11:35 Sponsored Presentation (Opportunity Available)

12:00 pm Luncheon Presentation (Sponsorship Opportunity Available) or Enjoy Lunch on Your Own

12:30 Session Break

DIGITAL COMPANIONS FOR DISEASE MANAGEMENT AND Rx COMPLIANCE

1:25 Chairperson’s Remarks

1:30 Digital Therapeutics as Companion to Pharmaceuticals: Lessons Learned and Perspectives
Pierre Leurent, CEO, Voluntis

1:55 Presentation to be Announced

2:20 Presentation to be Announced

2:45 Sponsored Presentation (Opportunity Available)

3:00 Refreshment Break with Exhibit and Poster Viewing

DTx COMMERCIALIZATION STRATEGIES: MARKET ACCESS AND VALUE MODELS

3:45 Chairperson’s Remarks
Adam Kaufman, PhD, President & CEO, Canary Health

3:50 Partnerships to Commercialize Digital Therapeutics
Adam Kaufman, PhD, President & CEO, Canary Health

4:15 Challenges and Potential Solutions in the Commercialization of Digital Therapeutics
David O'Reilly, Chief Platform Officer, Proteus Digital Health
For over a decade digital health has been heralded as a solution to unsustainable issues in health care. But the actual results have been disappointing. Despite continued investment there are few examples in the pharma, provider or payer sectors of early pilots and small-scale innovation demonstrations becoming real products and large-scale disruptive innovations. What is the right framework and timeline to think about how this will change so we can realize the promise of digital health?

4:40 PANEL DISCUSSION: Commercialization Strategies for Digital Therapeutics
Moderator: Adam Kaufman, PhD, President & CEO, Canary Health

5:30 Close of Day and Registration for Short Course

6:00-9:00 pm Dinner Short Course (separate registration required)


THURSDAY, JUNE 4

8:00 am Morning Coffee

EVIDENCE-BASED, PERSONALIZED DIGITAL THERAPEUTICS FOR CHRONIC CONDITIONS

8:30 Chairperson’s Remarks

8:35 Beyond DTx – Engaging the Patient Holistically to Optimize Outcomes
Olivier Jarry, Chief Commercial Officer, President, DarioHealth Corp
Digital Therapeutics is finally understood as a major, emerging component of healthcare, for the years to come. However, DTx companies may not have always delivered on outcomes and on clinical evidence with the same rigor as drugs or medical devices. DarioHealth brings together data from devices (e.g.; blood pressure), user generated (e.g.; food) and clinician generated (e.g.; observations) to demonstrate efficacy, safety, user satisfaction and ROI.

9:00 Digital Therapeutics for Mental Health: Improving Outcomes, Access and Scale for Mental Healthcare
Ken Cahill, CEO, SilverCloud Health
The presentation highlights the success of digital therapeutics for mental healthcare, specifically digital cognitive behavioral therapy (iCBT), as a complement to traditional psychological therapies. Results from SilverCloud’s major RCTs for digital mental health, will show how using iCBT can help to eliminate current barriers to mental healthcare. This can make effective mental health treatment more accessible, allowing for improved outcomes, scale and reduced care costs.

9:25 Presentation to be Announced

9:50 Sponsored Presentation (Opportunity Available)

10:05 Interactive Breakout Discussions Coffee Break

PLENARY SESSION: EVIDENCE-BASED DIGITAL MEDICINE

11:00 Chairperson’s Remarks

11:05 How Digital Health, Digital Medicine, and Digital Therapeutics Can Reshape Provider, Payer, Pharma, and Patient Collaboration
Ashish Atreja, MD, MPH, Assistant Professor, Chief Innovation Officer, Medicine, Icahn School of Medicine at Mount Sinai

11:30 Using Digital Solutions to Drive Real-World Research
Stella Safo, MD, MPH, Chief Clinical Transformation Officer, Vice President, Prospective Research, Premier, Inc.
This session will evaluate how digital solutions, from clinical decision support tools to population health performance management platforms, accelerate the breadth of insights that can be gleaned from real world research studies.

11:55 PANEL DISCUSSION: Real World Impact of Digital Medicine
Moderator: Ashish Atreja, MD, MPH, Assistant Professor, Chief Innovation Officer, Medicine, Icahn School of Medicine at Mount Sinai

12:30 pm Close of Conference

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag